INTerpath-001: Personalized mRNA Vaccine Improves Melanoma Outcomes | ESMO 2026

- Type
- Expert pick
- Congress
- ESMO 2026, day 2
- Published
- Topic
- Melanoma and skin

Listen to Oncology Here & Now
ESMO 2026On demandMadrid, October 23–27See the ESMO 2026 highlightsSubscribe to the newsletter
Dr. Mario BalsaHospital Clinic, Barcelona
Skin Cancer Beyond the TrialsDr. Mario BalsaDr. Mario Balsa. Expert pick. ESMO 2026. Day 2.
Publication pick. NEJM. October 9, 2026.
The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.